Segments - Electrosurgery Devices Market by Types (Electrosurgery Generators, Hand-held Instruments, Argon & Smoke Management Systems, Electrosurgical Instruments, and Electrosurgical Accessories), Technology (Monopolar Electrosurgery Devices, Bipolar Electrosurgery Devices, and Ultrasonic Devices), Applications (General Surgery, Cardiovascular Surgery, Cosmetic Surgery, Obstetric/Gynecological Surgery, Urological Surgery, Orthopedic Surgery, Oncological Surgery, Neuro Surgery, and Others), End-users (Ambulatory Surgery Centers, Specialty Clinics, Hospitals, and Research Laboratories & Academic Institutes), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The global electrosurgery devices market size was valued at around USD 5.62 billion in 2022 and is expected to surpass USD 9.58 billion by 2031, expanding at a CAGR of 6.1% during the forecast period, 2023–2031.
The market growth is attributed to the rising demand for medical and cosmetic surgeries as well as the wide popularity of minimally invasive surgical operations across healthcare institutions such as hospitals, clinics, and ambulatory surgical centers (ASCs).
Electrosurgery devices consist of several hand-held and automated devices that use electric power to perform several surgical tasks. These devices, primarily equipped with active electrodes and a generator, are mainly used for cutting and coagulating tissues in the body by applying or producing thermal destruction to the targeted tissues or surgical site.
In general, an electrosurgical pad is deployed and fixed on the patient’s body, especially the thigh, which acts as a resistance to the adverse electricity effects to the body. Several specialized electrosurgery equipment and accessories are also extensively deployed to support the devices during surgical operations.
These devices are widely installed across several healthcare units such as hospitals, clinics, and ablation centers performing ambulatory surgeries and have wide applications including cell treatment, tissue removal, and cosmetic surgeries. Unlike traditional surgical procedures, electrosurgical procedures ensure high accuracy, precision, and less time-taking surgeries for both cosmetic- and medical-surgical operations.
With technological advancements, electrosurgery devices are increasingly integrated with innovative techniques that help in the successful treatment of various surgical procedures. As a result, the devices offer certain advantages such as low-risk factors, ease to use, fast recovery time, and low chances of infection.
Due to these key aspects, the devices are predominantly used for various surgical operations including general surgery, cardiovascular surgery, obstetric/gynecological surgery, urological surgery, orthopedic surgery, oncological surgery, and neurosurgery. Moreover, electrosurgical procedures are widely integrated into dental diagnostics and surgical equipment due to the increasing demand for dental surgeries.
The market report finds that the COVID-19 pandemic had an adverse impact on the global electrosurgical devices market share due to the shifting focus to tackle the widespread virus that shattered the global economy. The pandemic forced medical device manufacturers to start developing a large chunk of several equipment and devices that helped in minimizing the virus spread and providing life-support systems for COVID-19 patients.
The overall manufacturing of medical devices was largely hampered due to the sudden disruption in the supply chain and limiting the logistic operations, which affected the timely supply of raw materials to device manufacturers. Existing projects and production of surgical devices had to be delayed and rescheduled owing to the lack of laborers and strict enforcement of preventive measures such as social distancing, imposed by lockdown emergencies.
During the pandemic, the rate of hospital visits and hospitalization by patients suffering from chronic illnesses and looking for surgical treatment sharply declined. Patients usually preferred home setting treatment during the pandemic as the chance of spreading the virus was very high at hospitals and clinics.
However, the increasing adoption of cardiovascular surgery, impacted by the rising cases of cardiovascular disease during the COVID-19 spread boosted the sales of these devices. With the rapid decline in the COVID-19 cases worldwide, the market is slowly coming back to its normal track and witnesses a fast recovery rate owing to the increasing demand for surgical treatments from chronic illness patients.
The research report presents a complete overview by providing detailed information about the current market trends, existing drivers, growth opportunities and potentials, and emerging challenges. The global electrosurgery market report has up-to-date insights about market dynamics and market scenarios that can shape the overall market performance and output during the forecast period, 2022 to 2030.
Growing demand for cosmetic surgery among young adults and teenagers is a major market trend, which is likely to fuel the market growth significantly in the coming years. As per the report of the International Society of Aesthetic Plastic Surgery, nearly 11.4 million cosmetic operations were reported globally in 2019, which showed a 7.1% increase in surgery compared to the previous year.
Electrosurgical devices are widely used in minimally invasive cosmetic surgeries as these devices facilitate easy-to-use and highly-precision performance in cosmetic surgery. Several electrosurgery instruments such as electrofulguration, electrocoagulation, and electrodesiccation are extensively adopted for the reconstruction of facial defects due to diseases, birth disorders, burns, and trauma.
The instruments are largely applied for facial alterations and hair removals. As per a global report, the US alone had registered cases of about 1.4 million cosmetic surgery procedures in 2019.
Rising number of patients suffering from chronic diseases worldwide and the growing geriatric population present key drivers of the market. As per several global reports, the worldwide cases of chronic diseases are rising significantly over the years and millions of people are at high risk of exposing to such illnesses in near future.
According to the World Health Organization (WHO), major chronic illnesses such as cancer, heart disease, diabetes, chronic lung disease, and stroke accounted for nearly 70% of the total number of deaths globally in 2020. WHO estimated that more than 16 million people across the globe died prematurely, especially in low- and middle-income countries due to widespread chronic illnesses.
According to the 2018 report published by the Centers for Disease Control and Prevention (CDC), cardiovascular diseases caused nearly 850,000 deaths in the US alone, which was the primary cause of death in the country. The rising cases of skin cancer in the US represented a big threat to hundreds of its population.
The demand for minimally invasive techniques for surgeries is rising globally and the rising investment from key players in the development of several innovative non-invasive surgical devices is boosting the overall market revenue.
Ranging from cosmetic to medical surgeries, the minimally invasive method is widely used as a key surgical method owing to its major benefits such as safety, high accuracy, and time-saving surgical procedures.
Compared with conventional surgical procedures, non-invasive procedures using laser electrosurgical technologies offer effective surgical operations for patients having cardiac valve disorders, ophthalmic disorders, and liver cancer.
The global minimally invasive surgical systems market size was worth USD 27.9 billion in 2021 and is expected to surpass USD 53.7 billion by 2030, expanding at a CAGR of 7.5% from 2023 to 2031.
The risk of overheating and heat damage related to laparoscopic surgery devices is high if a surgeon misidentifies the anatomic structures of the devices. Since the operations of the devices are complex, the electrosurgery treatment can occur thermal damage to those non-targeted tissues and cause excessive burn to the skin.
Moreover, the high cost of surgical procedures using electrosurgery devices acts as another major restraint, which can hamper the market growth during the forecast period.
Electrosurgery devices involve the circulation of high-voltage of electric current to produce the required heat for tissue surgeries. The thermal destruction of targeted tissues usually produces surgical smoke that contains toxic gases and inhaling such gases are harmful to both patients and surgeons.
The release of surgical smoke can cause several symptoms including irritation of the throat, headache, asthma, and nasal congestion to those people involved during the surgery, which affected over half a million healthcare workers.
Various research confirmed that the use of laser electrosurgical devices increased the rate of transmission of HPV infection, which is transmitted through skin-to-skin contact. A large number of healthcare workers including surgeons and nurses are often exposed to surgical smoke every year globally. However, the advancement in smoke management systems in using electrosurgery devices is likely to minimize the existing problem.
The presence of high unmet demand for such techniques, especially in developing countries presents lucrative growth opportunities for the market. The rising demand for advanced medical devices in these countries is largely influenced by the increasing spending on healthcare issues and active governments’ initiatives for the development of medical infrastructures.
With the widespread prevalence of chronic diseases among a large pool of the elderly population and the rising patients’ awareness regarding the available advanced surgical devices, the market has enormous growth potential in near future.
With technological advancements, major market players started developing innovative electrosurgery devices that are mainly equipped with various advanced technologies such as Machine Learning (ML), Artificial Intelligence (AI), and the Internet of Things (IoT).
The rapid update of technologies in these devices offers effective results and high performance in surgical operations, especially on those sensitive surgeries that require high precision and accuracy.
Spine surgeries, cranial surgical procedures, and neurological surgeries are some major surgeries that need great precision and the use of reliable techniques to ensure better surgical results. Such development further creates various lucrative growth opportunities for the market.
The report on the global electrosurgery devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Electrosurgery Devices Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Types (Electrosurgery Generators, Hand-held Instruments, Argon & Smoke Management Systems, Electrosurgical Instruments, and Electrosurgical Accessories), Technology (Monopolar Electrosurgery Devices, Bipolar Electrosurgery Devices, and Ultrasonic Devices), Applications (General Surgery, Cardiovascular Surgery, Cosmetic Surgery, Obstetric/Gynecological Surgery, Urological Surgery, Orthopedic Surgery, Oncological Surgery, Neuro Surgery, and Others), and End-users (Ambulatory Surgery Centers, Specialty Clinics, Hospitals, and Research Laboratories & Academic Institutes) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
Boston Scientific Corporation; B. Braun Melsungen AG; Medtronic; Olympus Corporation; Ethicon USA, LLC.; Smith & Nephew plc.; BOVIE MEDICAL; BOWA-electronic GmbH & Co. KG; Kirwan Surgical Products, LLC; CONMED Corporation; Parkell, Inc.; ATMOS MedizinTechnik GmbH & Co. KG; and Utah Medical Products, Inc. |
Based on types, the global market is divided into electrosurgery generators, hand-held instruments, argon & smoke management systems, electrosurgical instruments, and electrosurgical accessories.
The electrosurgical instruments segment accounted for a major market share in 2021 and is expected to expand at a CAGR of 4.5% during the forecast period owing to the wide use of these instruments for various surgical operations, especially cosmetic surgery.
An array of instruments such as electrosurgical electrodes & pencils, patient return electrodes, laparoscopic instruments, suction coagulators & irrigation devices, cords, adapters, and bipolar forceps are widely used as key instruments for surgical procedures across clinics, hospitals, and ASCs. These instruments are primarily designed to facilitate optimal performance during surgical operations.
The hand-held segment held a sizeable market revenue in 2021 and is anticipated to hold a key share of the market in the coming years due to the rising demand for disposable hand-held instruments from healthcare institutions. Compared to other products, hand-held devices are comparatively cheaper in price and used as disposable instruments, which helped in gaining traction for these devices.
Moreover, the wide application of hand-held devices in various surgical treatments and rapid introduction of innovative product offerings of the device types from market players further boosts the segment growth.
In terms of technology, the global market is segmented into monopolar electrosurgery devices, bipolar electrosurgery devices, and ultrasonic devices.
The bipolar electrosurgery devices segment accounted for significant revenue growth in 2021 and is projected to hold a major market share in the coming years owing to the high demand for safer and easy-to-use surgical devices from healthcare organizations.
As compared to monopolar electrosurgery devices, bipolar devices offer more accuracy and high performance in surgical procedures. As a result, bipolar devices are widely used in sensitive surgical operations associated with otolaryngology, urology, neurology, and ophthalmology.
The rising preference for bipolar technology is mainly due to certain advantages such as lower power consumption and being highly effective for small areas of surgical operation. The monopolar electrosurgery devices segment is anticipated to expand at a significant growth during the projected period since the devices are best suitable for large area operations and are extensively used for various applications including desiccation, blend, cut, and fulguration.
Monopolar electrosurgery includes a pencil instrument that places active electrodes in the surgical entry site and facilitates effective performance in cut tissue and coagulates bleeding. The “Bovie pen” is a key monopolar instrument available and widely used by all surgical specialties for almost every surgical treatment. The instrument can be used for various settings and is extensively adopted to conduct several tissue surgeries.
On the basis of applications, the global market is segregated into general surgery, cardiovascular surgery, cosmetic surgery, obstetric/gynecological surgery, urological surgery, orthopedic surgery, oncological surgery, neuro surgery, and others.
The general surgery segment constituted a dominant market share in 2021 and is projected to register a considerable growth rate during the projected period owing to the rising cases of chronic and acute illnesses related to head & neck, blood vessels, digestive tract, breast, and abdomen. General surgeons are highly-skilled doctors that perform surgeries on commonly occurred health conditions such as hernias, gallbladder problems, appendicitis, and intestinal issues.
The segment growth is extensively attributed to the increasing geriatric population, the rapid expansion of surgical centers including ASCs, and rising governments’ policies for developing healthcare infrastructure for ensuring advanced general surgery.
The orthopedic surgery segment is expected to expand at a CAGR of more than 5.6% during the forecast period owing to the wide prevalence of bone & muscle-related problems, especially among the geriatric population.
The increasing demand for surgical treatments related to the correction of bone deformities, injuries, and disorders as well as the high rate of skeleton injuries and associated problems including ligaments and tendons further fuels the segment growth. The orthopedic-related issues are mainly caused due to the lack of physical exercise and a low intake of vitamins and minerals.
Based on end-users, the global market is categorized as ASCs, specialty clinics, hospitals, and research laboratories & academic institutes.
The hospitals segment held a major market share in 2021 and is anticipated to expand at a steady growth rate during the projected period owing to the high rate of patient admission to hospitals for surgical treatments. The rising cases of hospitalization are mainly driven by the wide availability of advanced medical devices for surgeries such as minimally invasive procedures as well as the presence of specialized doctors and health professionals in hospitals.
On the other hand, the ASCs segment is expected to constitute a large market share in the coming years owing to the increasing establishment of ASCs across regions. The rapid expansion of the surgery centers is largely influenced by the rising demand for electrosurgery procedures that require short stays for patients.
In terms of regions, the global market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa.
The North America market size was valued at USD 3.9 billion in 2021 and the region is expected to dominate the market during the projected period owing to the early adoption of advanced electrosurgery equipment for various surgical treatments.
The presence of a large pool of the geriatric population, who are at high risk of various chronic diseases, and the rising acceptance of minimally invasive surgical procedures among patients present key factors driving the regional market.
Moreover, the region has a well-developed healthcare infrastructure due to the rising spending on the installation of high-technology medical devices from healthcare institutions such as hospitals and clinics. As per the estimation of the Organisation for Economic Co-operation and Development (OECD), the total healthcare expenses of the US and Canada annually are 17.9% and 11% of their GDP respectively.
Furthermore, the presence of key global players in the region, especially in the US, and the wide patients’ preference for minimally invasive surgical procedures play crucial roles in the market growth in North America. The North America minimally invasive devices market has huge growth potential due to the rising demand from patients.
The Asia Pacific market accounted for a significant market share in 2021 and is anticipated to expand at a robust growth rate in the coming years owing to the widespread trend for cosmetic surgeries among teenagers and the high prevalence of chronic diseases in the region.
Furthermore, the rising awareness among patients regarding the availability of advanced surgical procedures such as minimally invasive surgeries for various chronic illness treatments further boosts the regional market growth.
The increasing demand for general surgery among the geriatric population and the rising governments’ initiatives across major economies for developing healthcare infrastructure are major factors fueling the market growth in Asia Pacific.
The global electrosurgery devices market has been segmented on the basis of
Key players competing in the global market are Boston Scientific Corporation; B. Braun Melsungen AG; Medtronic; Olympus Corporation; Ethicon USA, LLC.; Smith & Nephew plc.; BOVIE MEDICAL; BOWA-electronic GmbH & Co. KG; Kirwan Surgical Products, LLC; CONMED Corporation; Parkell, Inc.; ATMOS MedizinTechnik GmbH & Co. KG; and Utah Medical Products, Inc. The market is mainly consolidated due to the domination by a few key market players, capturing the majority of revenue share.
However, the rising entry of local and regional players, especially in developing countries is likely to increase the competition level of the global market. With the increasing competition among players, many of these medical device manufacturers are widely focusing on the development of innovative technologies to enhance the performance of key components including bipolar instruments and electrosurgery generators.
Some of these major companies have adopted a series of business development strategies including merger and acquisition, entering into partnerships and collaboration, product launches, and production capacity expansion to expand their consumer base and enhance their market share.
For instance,
On May 26, 2022, an Ireland-US based medical device manufacturing company, Medtronic announced that it entered into a collaboration with a US-based healthcare service provider, DaVita Inc. Both companies agreed to share their technologies and expertise to form a new and independent company called “NewCo”, which was aimed to dedicate for improving the existing treatment experience of kidney patients. The new company, co-owned by both companies having equal equity stakes, would be developing kidney care-focus medical devices.
On June 21, 2021, Ethicon USA, LLC., a subsidiary of US-based pharmaceutical company, Johnson & Johnson announced the launch of a new and advanced bipolar energy device called the ENSEAL X1 Curved Jaw Tissue Sealer. The device was designed to enhance efficiency in surgical procedures by providing easy access to and sealing of tissues, which could be applicable for gynecological, thoracic procedures, bariatric surgery, and colorectal procedures.
The global market size was valued at around USD 5.62 billion in 2022 and is expected to surpass USD 9.58 billion by 2031.
The electrosurgical instruments segment accounted for a major market share in 2021 and is expected to expand at a CAGR of 4.5% during the forecast period.
The key drivers of the market include the rising demand for medical and cosmetic surgeries as well as the wide popularity of minimally invasive surgical operations across healthcare institutions such as hospitals, clinics, and ASCs.
For regional analysis, the North America market size was valued at USD 3.9 billion in 2021 and the region is expected to dominate the market during the projected period.
The key market players are Boston Scientific Corporation; B. Braun Melsungen AG; Medtronic; Olympus Corporation; Ethicon USA, LLC.; Smith & Nephew plc.; BOVIE MEDICAL; and others.